Unknown

Dataset Information

0

Treatment strategies and risk of central nervous system recurrence in high-grade B-cell and Burkitt lymphoma.

ABSTRACT:

SUBMITTER: Decker DP 

PROVIDER: S-EPMC6944747 | biostudies-literature | 2020 Jan

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Treatment strategies and risk of central nervous system recurrence in high-grade B-cell and Burkitt lymphoma.

Decker Dominic P DP   Egan Pamela C PC   Zayac Adam S AS   Treaba Diana O DO   Olszewski Adam J AJ  

Leukemia & lymphoma 20190821 1

Similar Datasets

Unknown Primary central nervous system lymphoma.
| S-EPMC9437714 | biostudies-literature
Unknown Clonal evolution in diffuse large B-cell lymphoma with central nervous system recurrence.
| S-EPMC7807834 | biostudies-literature
Unknown Recent advances in treatment of primary central nervous system lymphoma.
| S-EPMC3841579 | biostudies-literature
Unknown Treatment Strategies and Prognostic Factors in Secondary Central Nervous System Lymphoma: A Multicenter Study of 124 Patients.
| S-EPMC10365212 | biostudies-literature
Unknown Hepatotoxicity from high-dose methotrexate in primary central nervous system lymphoma.
| S-EPMC10180358 | biostudies-literature
Unknown Primary Central Nervous System Lymphoma: Molecular Pathogenesis and Advances in Treatment.
| S-EPMC6371000 | biostudies-literature
Unknown Progress of radiological‑pathological workflows in the differential diagnosis between primary central nervous system lymphoma and high‑grade glioma (Review).
| S-EPMC9773014 | biostudies-literature
Unknown P11.05LENALIDOMIDE IN THE TREATMENT OF RELAPSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL)
| S-EPMC4185581 | biostudies-literature
Unknown Clonal identification and homology differentiate primary central nervous system lymphoma from non-central nervous system lymphoplasmacytic lymphoma: a case report.
| S-EPMC12639785 | biostudies-literature
Unknown Predicting prognosis outcomes of primary central nervous system lymphoma with high-dose methotrexate-based chemotherapeutic treatment using lipidomics.
| S-EPMC11306931 | biostudies-literature